Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
India’s mutual fund industry clocks 7X growth in 10 years, equity funds garner Rs 86K crore in inflows : Motilal Oswal Mutual Fund (...)
4/08/2025
Sebi pushes for structural reforms in derivatives after Jane Street fallout : Report
4/08/2025
Adani Power shares rise 2% after board approves 1:5 stock split
4/08/2025
Reliance Power, Reliance Infra shares tumble 5% amid ED Probe into Rs 17,000 crore loan fraud
4/08/2025
ABB India shares tumble nearly 4% as Q2 profit slides 21% YoY
4/08/2025
PC Jeweller shares rally 6% after management signals debt-free roadmap by FY26-end
4/08/2025
